Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effectiveness of laparoscopic removal of isolated superficial peritoneal endometriosis for the management of chronic pelvic pain in women (ESPriT2): protocol for a multi-centre randomised controlled trial.

Trials·2023

Same author

ESHRE guideline: endometriosis.

Human reproduction open·2022

Same author

The Emotional Dysregulation Questionnaire: Development and comparative analysis.

Psychology and psychotherapy·2020

Same author

The Effect of Increasing Topsoil Disturbance on Surface-Active Invertebrate Composition and Abundance under Grazing and Cropping Regimes on Vertisols in North-West New South Wales, Australia.

Insects·2020

Same author

Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019

Same author

Enhancing the health and safety of migrant workers.

Journal of travel medicine·2019

Search research articles

Related Experiment Videos

Is premigration health screening for tuberculosis worthwhile?

Kathleen King¹, Paul J Douglas, Ken Beath

¹Global Health Branch, Department of Immigration and Citizenship, Sydney, NSW.

The Medical Journal of Australia

|November 9, 2011

Summary

Premigration screening for tuberculosis identifies many visa applicants needing treatment, benefiting both individuals and Australia by preventing disease spread. This process effectively targets high-risk groups for tuberculosis detection.

Related Experiment Videos

Area of Science:

Public Health
Infectious Disease Epidemiology
Immigration Health

Background:

Tuberculosis (TB) remains a global health concern, necessitating strategies to prevent its introduction into non-endemic countries.
Premigration health assessments are a key component of immigration policies to identify and manage communicable diseases.
Evaluating the effectiveness and resource allocation of TB screening for visa applicants is crucial for public health.

Purpose of the Study:

To assess the value of premigration tuberculosis screening for visa applicants.
To determine if screening resources are optimally directed towards individuals at the highest risk of tuberculosis.

Main Methods:

A 12-month survey (July 2009-June 2010) of intending migrants diagnosed with active tuberculosis during premigration health assessments.
Analysis of medical examinations submitted to the Department of Immigration and Citizenship's Global Health Branch.
Inclusion of diagnostic methods (sputum smear, culture), susceptibility testing, and visa categories.

Main Results:

519 individuals were diagnosed with active tuberculosis (prevalence: 137 per 100,000).
Top source countries included the Philippines, India, Vietnam, and China.
Students (31.2%), visitors (15.8%), and humanitarian visa applicants (10.2%) represented a significant proportion of those diagnosed.

Conclusions:

Premigration screening effectively identifies substantial numbers of individuals requiring tuberculosis treatment before arrival in Australia.
The high prevalence of tuberculosis among students, visitors, and humanitarian entrants validates the current screening program.
Screening benefits visa applicants through early treatment and protects the Australian population by preventing exposure to active tuberculosis.